US Appellate Court Hands Siemens Big Win In False Advertising Suit
The Ninth Circuit Court of Appeals upheld a lower court’s decision that false advertising claims made against Siemens Medical Solutions by a competitor had no basis for trial.
You may also be interested in...
The Affordable Care Act requires health insurers to cover contraceptives; some lawmakers in the US House want to make sure those requirements are upheld.
The US FDA issued a safety communication to patients and health care providers about the potential for overdose when using ENFit low dose tip syringes, and also told manufacturers to update labeling to account for the risk.
The US FDA’s most recent guidance revises UDI requirements for class I and unclassified medical devices the agency issued in July. Class I devices categorized as consumer health products will be exempt from some submission requirements.